Stone X Group Inc. Vyne Therapeutics Inc. Transaction History
Stone X Group Inc.
- $2.29 Trillion
- Q3 2025
Shares
1 transactions
Others Institutions Holding VYNE
# of Institutions
4Shares Held
52.2KCall Options Held
0Put Options Held
0-
Staley Capital Advisers Inc51.5KShares$19,0440.0% of portfolio
-
Fortitude Family Office, LLC Scottsdale, AZ680Shares$2510.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA16Shares$50.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $21.5M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...